Implied Volatility Surging for Novartis Stock Options

13.05.26 15:03 Uhr

Werte in diesem Artikel
Aktien

126,28 CHF 0,28 CHF 0,22%

Indizes

1.480,3 PKT -6,2 PKT -0,42%

2.975,3 PKT 0,8 PKT 0,03%

2.143,9 PKT 0,6 PKT 0,03%

10.609,7 PKT -6,8 PKT -0,06%

2.263,6 PKT -16,7 PKT -0,73%

14.130,8 PKT -101,2 PKT -0,71%

1.937,2 PKT -14,5 PKT -0,74%

19.954,4 PKT -96,4 PKT -0,48%

3.598,0 PKT 5,1 PKT 0,14%

5.342,3 PKT -32,4 PKT -0,60%

19.785,9 PKT -95,4 PKT -0,48%

7.772,4 PKT -3,3 PKT -0,04%

Investors in Novartis AG NVS need to pay close attention to the stock based on moves in the options market lately. That is because the Jun 18, 2026 $70 Call had some of the highest implied volatility of all equity options today.What is Implied Volatility?Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that may cause a big rally or a huge sell-off. However, implied volatility is only one piece of the puzzle when putting together an options trading strategy.What do the Analysts Think?Clearly, options traders are pricing in a big move for Novartis shares, but what is the fundamental picture for the company? Currently, Novartis is a Zacks Rank #3 (Hold) in the Large Cap Pharmaceuticals industry that ranks in the Top 37% of our Zacks Industry Rank. Over the last 30 days, no analysts have increased their earnings estimates for the current quarter, while two analysts have revised their estimates downward. The net effect has taken our Zacks Consensus Estimate for the current quarter from $2.28 per share to $2.21 in that period.Given the way analysts feel about Novartis right now, this huge implied volatility could mean there’s a trade developing. Oftentimes, options traders look for options with high levels of implied volatility to sell premium. This is a strategy many seasoned traders use because it captures decay. At expiration, the hope for these traders is that the underlying stock does not move as much as originally expected.Looking to Trade Options?Check out the simple yet high-powered approach that Zacks Executive VP Kevin Matras has used to close recent double and triple-digit winners. In addition to impressive profit potential, these trades can actually reduce your risk.Click to see the trades now >>This article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Quelle: Zacks

Nachrichten zu Novartis AG

Analysen zu Novartis AG

DatumRatingAnalyst
25.06.2026Novartis BuyDeutsche Bank AG
11.06.2026Novartis HoldJefferies & Company Inc.
09.06.2026Novartis BuyDeutsche Bank AG
04.06.2026Novartis HoldJefferies & Company Inc.
27.05.2026Novartis BuyDeutsche Bank AG
DatumRatingAnalyst
25.06.2026Novartis BuyDeutsche Bank AG
09.06.2026Novartis BuyDeutsche Bank AG
27.05.2026Novartis BuyDeutsche Bank AG
05.05.2026Novartis OverweightJP Morgan Chase & Co.
29.04.2026Novartis BuyDeutsche Bank AG
DatumRatingAnalyst
11.06.2026Novartis HoldJefferies & Company Inc.
04.06.2026Novartis HoldJefferies & Company Inc.
29.04.2026Novartis NeutralUBS AG
29.04.2026Novartis Equal WeightBarclays Capital
28.04.2026Novartis HaltenDZ BANK
DatumRatingAnalyst
29.04.2026Novartis SellGoldman Sachs Group Inc.
31.03.2026Novartis SellGoldman Sachs Group Inc.
20.03.2026Novartis SellGoldman Sachs Group Inc.
04.02.2026Novartis SellGoldman Sachs Group Inc.
21.01.2026Novartis SellGoldman Sachs Group Inc.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Novartis AG nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen